Our results show that higher BMPR2 expression is associated with higher pathological stage and poorer survival, and also illustrate the antineoplastic effects of siBMPR2 on chondrosarcoma cells in vitro and in vivo. This evidence concerns the gene BMPR2 and chondrosarcoma.